uprosertib
Showing 1 - 3 of 3
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Canada (Laboratory Biomarker Analysis, Pharmacological
Completed
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Laboratory Biomarker Analysis
- +3 more
-
Calgary, Alberta, Canada
- +4 more
Feb 10, 2022
Recurrent Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in France, United Kingdom, United States (Laboratory Biomarker
Completed
- Recurrent Uveal Melanoma
- Stage IV Uveal Melanoma AJCC v7
- Laboratory Biomarker Analysis
- +3 more
-
Atlanta, Georgia
- +6 more
Feb 14, 2020
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma Trial in United States
Completed
- Endometrial Adenocarcinoma
- +5 more
- Laboratory Biomarker Analysis
- +2 more
-
Hartford, Connecticut
- +21 more
Oct 13, 2020